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abstract

results

Hydrophilic GNPs:

Gold Nanoparticles (GNPs)

• Citrate(-)
• Carboxymethyl cellulose, CMC(-)
• Polyethylene imine, PEI(+)
• Polyethylene glycol, PEG(0)
• Dipalmitoylphosphatidylcholine, DPPC
(+/-).
o Determine hydrophilic GNP effect on leakage
when exteriorly bound to phospholipid
vesicles
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Experiments with GNPs:
• Determine how to control the size and distribution of size
• Conduct experiments varying size of nanoparticles in
vesicles
• Conduct experiments to determine temperature of release
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As the data shows the fractionation
does a very good job of creating
different size dispersions. The range
and the number average (mean) show
exactly how well the fractionation
process works. Also, the standard
deviation continues to lower as the
percent of methanol is raised. This is
desired for the present because the
lowest size is the most important, but
more monodispersed distributions for
higher averages will be required as
research continues. Procedures will be
developed to lower the standard
deviation of the lower percent methanol
fractionations.

Nanoparticle Characterization:
•

•
•

Hydrodynamic diameter accounts for the gold
core, the ligand length, and the hydrodynamic
barrier surrounding the NP
Poly-dispersity index (PDI) shows that our
solutions contain a range of sizes, or
conglomerates
Zeta results need to be near +/- 30
UV – VIS shows that colloidal gold exists in
solution

Table displaying the nanoparticles’ characterizations:
• Variance in expected sizes or zeta potentials display the need to perform
dilutions of the samples and/or filter the samples to ensure no
conglomerates are present in the samples which could skew results.

Importance of Characterization:
•

•

Alterations in the nanoparticle surface chemistry
and ligand types can engender different effects on
the leakage rates and stability.
Understanding the variances between the surface
chemistries of the nanoparticles provides an
accurate evaluation and analysis of these effects.

Nanoparticles and Liposomes:
• In order to create the vesicle-nanoparticle
assembly, nanoparticles can be synthesized and
then exteriorly associated with vesicles through
electrostatic adsorption.

Future Goals:

• Size and hydrophilicity will increase rate of fluorescent dye
release.
• GNPs will cause enhancement of fluorescent dye

•
•
•
•
•
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Hypothesis:

Hydrophobic GNPs:
DDT is used as capping agent
Size range is 2-6 nm for averages
Drugs are encapsulated in vesicle
Particles embedded in bilayer
GNPs are used to disrupt the vesicle
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research goals
1. Perform various gold nanoparticle syntheses and analyze the varying size,
surface chemistry, and hydrophilicity the nanoparticles to determine their
effects on drug delivery.
2. Measure the leakage rate of fluorescent dye from lipid-nanoparticle vesicles to
simulate stimuli responsive drug delivery.
3. Tailor nanoparticle surface chemistry to increase stability and bioavailability,
decrease macrophage uptake, and enable site-specific targeting.

Histogram for 70% Fractionation
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In the near future, new pharmaceutical therapeutics will evolve to contain complicated protein
molecules, gene therapies, etc., which must be transported in extremely specific environments
such as a specific pH level or sodium concentration. The problem is that throughout the body
there are many different environments that a drug could pass through. For example, gastric
acid can have pH levels as low as 1 where blood is around 7.4. This is a problem because as
the drugs pass through these harsh environments they may become rendered useless.
Furthermore, these new therapeutics are not compatible with conventional drug delivery
mechanisms and new strategies for drug delivery are required. To solve these problem
phospholipid vesicles are being used with gold nanoparticles to transport these drugs. The
vesicles encapsulate the drug of choice and protect it from the harsh environments of the body.
The gold nanoparticles can be designed to either embedded in the lipid bilayer of the vesicles
or decorate the vesicle exterior. When radiation is applied, the nanoparticles are excited and
cause a disruption in the vesicle structure, leading to the release of the drug into the body. Our
research is centered around how the stability of the lipid vesicles changes based on the size,
surface chemistry, and distribution of the nanoparticles.

Histogram for 50% Fractionation

• To determine nanoparticle effects on drug delivery when
exteriorly bound to lipid vesicles as well as determining the
effect of the particles on fluorescent dye—quenching or
enhancement

UV-Vis data displaying the wavelength and absorbance
for 5 nm Citrate GNPs:
• Shows a peak approximately around 500 nm
• This peak demonstrates what wavelength the particles
absorb at and, therefore, would have to be irradiated at in
order to get nanoparticle heating.

Image of various types of GNPs:
(Left to Right) CMC, 5nm PEI, PEG, Citrate 20 nm

medical implications
The vesicles will help the medicine inside travel through
the harsh conditions that they will have to endure while
inside the body. The vesicles can be tracked in the blood
stream and then leaked into the body when thermal
radiation is applied. The vesicles must be stable enough to
endure the temperature of the body without rupturing, but
must also break under temperatures that the human body
can easily tolerate. If this can be achieved, then the patient
will be put under the least amount of stress and the
medicine will be delivered most efficiently.

• The variations in surface chemistry can either produce a
quenching or enhancement effect on the fluorescence
emitted. Once these effects are analyzed and a control
curve is obtained, the measurement of the leakage rate of
dye will be determined.

a.

• The development of the nanoparticle-lipid vesicle assembly
will provide a new mechanism for drug delivery for patients
that can provide site specific targeting upon thermal
stimulation.
• This targeting system can be utilized to release the desired
medication to specific sites within the body; thus, replacing
the current technique of full body chemical treatment such as
chemotherapy.
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